after ≥12 months of therapy), we conditionally recommend continuing current OP therapy or switching to another class of OP medication (PICO 13.5-13.6). For adults ≥40 years continuing chronic GC who discontinue DEN, we strongly recommend starting an antiresorptive over not starting OP medication (PICO 13.1, 13.3, 13.5). DEN remains effective at longer than 10 years in patients with postmenopausal OP. However, discontinuation of DEN after two or more doses has been associated with rapid loss of